Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Shengshui Gao (JPSSG) is a traditional Chinese medicine (TCM) herbal paste formulation primarily used to treat cancer-related fatigue (CRF). It is a multi-component botanical modality containing approximately 87 identified bioactive compounds that target skeletal muscle health. Its mechanism of action involves the activation of the AMPK-SIRT1 and HIF-1 signaling pathways, which helps alleviate skeletal myoblast cell apoptosis, reduce oxidative stress, and improve mitochondrial dysfunction. Clinical and preclinical studies have explored its efficacy in patients with non-small cell lung cancer (NSCLC) following chemotherapy to improve fatigue and immune function. It is typically prepared as a concentrated semi-solid paste for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Shengshui Gao.